Point State Capital LP Moderna, Inc. Transaction History

Point State Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $504,575 - $937,849	-3,990 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $155,815 - $254,271	690 Added 20.91%	3,990 $1.01 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $1.49 Million - $3.25 Million	-6,700 Reduced 67.0%	3,300 $1.27 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $1.3 Million - $2.35 Million	10,000 New	10,000 $2.35 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $1.64 Million - $2.79 Million	-15,000 Closed	0 $0

Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $1.09 Million - $1.9 Million	-20,000 Reduced 57.14%	15,000 $1.06 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $1.04 Million - $2.8 Million	35,000 New	35,000 $2.25 Million

1,039

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.